News for 'Sun Pharma'

Sensex, Nifty fall as high oil prices, foreign fund outflows weigh

Sensex, Nifty fall as high oil prices, foreign fund outflows weigh

Rediff.com29 Sep 2026

Indian equity benchmark indices, Sensex and Nifty, extended their losses for a second consecutive day, driven by elevated crude oil prices, persistent foreign institutional investor (FII) outflows, and high US Treasury yields.

Stock Markets Today: Sensex, Nifty Fall as Crude Oil Prices Surge, Foreign Funds Exit

Stock Markets Today: Sensex, Nifty Fall as Crude Oil Prices Surge, Foreign Funds Exit

Rediff.com29 Sep 2026

Indian equity benchmark indices Sensex and Nifty experienced a significant tumble in early trade, primarily driven by elevated crude oil prices due to ongoing West Asia uncertainty and substantial foreign fund outflows. Track Sensex, Nifty on September 29.

Indian Pharma Firms Deepen US Investment in Specialty Drugs Amidst Generic Pressure

Indian Pharma Firms Deepen US Investment in Specialty Drugs Amidst Generic Pressure

Rediff.com2 Jun 2026

Indian pharmaceutical companies are strategically increasing investments in the US market, focusing on specialty drugs, complex generics, respiratory products, and local manufacturing, despite a nearly 10 per cent fall in exports to the US in FY26 due to pricing pressure and competition in traditional generics.

Sensex, Nifty Rebound as Global Cues Ease Rate Hike Fears

Sensex, Nifty Rebound as Global Cues Ease Rate Hike Fears

Rediff.com5 Oct 2026

Indian benchmark equity indices, Sensex and Nifty, closed higher on Monday, driven by softer-than-expected US jobs data which reduced expectations of aggressive monetary tightening by the US Federal Reserve, boosting risk appetite across emerging markets.

Sensex, Nifty fall for third day on crude prices, FII outflows

Sensex, Nifty fall for third day on crude prices, FII outflows

Rediff.com30 Sep 2026

Indian benchmark indices Sensex and Nifty extended their losses for a third consecutive day, driven by firm crude oil prices, elevated global bond yields, and significant foreign fund outflows, making investors cautious.

Piramal Pharma looks to return on growth path

Piramal Pharma looks to return on growth path

Rediff.com8 May 2026

Piramal Pharma anticipates a significant turnaround in financial year 2026-27 (FY27), projecting early-to-mid teens revenue expansion and a sharp improvement in profitability, driven by improved business momentum, new product acquisitions, and structural tailwinds.

Strong Demand Fuels India's Manufacturing Growth to 7-Month High

Strong Demand Fuels India's Manufacturing Growth to 7-Month High

Rediff.com1 Oct 2026

India's manufacturing sector activity surged to a seven-month high in September, driven by a significant acceleration in new orders and output, leading to solid expansion in factory hiring and a four-month peak in business optimism.

Sensex Plunges 1,045 Points, Nifty Hits 52-Week Low Amid FII Selling, RBI Tightening

Sensex Plunges 1,045 Points, Nifty Hits 52-Week Low Amid FII Selling, RBI Tightening

Rediff.com8 Oct 2026

The Indian stock market experienced a significant downturn, with the Sensex crashing over 1,000 points and the Nifty hitting a fresh 52-week low, driven by sustained selling from foreign institutional investors, the RBI's monetary policy tightening, and elevated Brent crude prices.

Indian Equities Close Marginally Lower as Oil Cools, IT Stocks Gain

Indian Equities Close Marginally Lower as Oil Cools, IT Stocks Gain

Rediff.com11 Sep 2026

Indian benchmark indices, Sensex and Nifty, ended marginally lower after recovering from sharp intraday losses, driven by cooling crude oil prices and buying interest in HDFC Bank and IT sector stocks.

Stock Markets Today: Sensex, Nifty climb as oil prices cool, foreign funds return

Stock Markets Today: Sensex, Nifty climb as oil prices cool, foreign funds return

Rediff.com21 Sep 2026

Indian benchmark indices, Sensex and Nifty, saw gains in early trade, driven by a notable drop in crude oil prices and renewed buying interest from Foreign Institutional Investors (FIIs).

Pharma distributor's licence cancelled over Kota C-section deaths

Pharma distributor's licence cancelled over Kota C-section deaths

Rediff.com26 Jun 2026

The World Health Organization has requested information from the Indian government regarding the alleged supply of spurious oxytocin injections linked to the deaths of five women in Kota hospitals. This comes after regulatory action, including the cancellation of manufacturing licenses for Jackson Laboratories units, following joint inspections by drug control bodies. The government is investigating the matter, emphasising a zero-tolerance approach to quality violations.

Sun Pharma's $11.75 Billion Organon Acquisition: A Strategic Leap

Sun Pharma's $11.75 Billion Organon Acquisition: A Strategic Leap

Rediff.com27 Apr 2026

Sun Pharmaceutical Industries Ltd has announced its acquisition of US-based Organon & Co in an all-cash deal valued at an enterprise valuation of USD 11.75 billion, aiming to become a top 25 global pharmaceutical company.

Stock Markets Today: Sensex, Nifty Pare Early Gains; Now Trading in Red

Stock Markets Today: Sensex, Nifty Pare Early Gains; Now Trading in Red

Rediff.com22 Sep 2026

Indian benchmark indices Sensex and Nifty opened higher, extending gains from the previous session, driven by a rally in global markets and a slight cooling in crude oil prices. Optimism around a potential meeting between US and Iranian presidents also contributed to positive sentiment.Later both indices pared gains and were trading in red. Track Sensex, Nifty on September 22.

What Dilip Shanghvi said on Sun Pharma's Organon Buy

What Dilip Shanghvi said on Sun Pharma's Organon Buy

Rediff.com27 Apr 2026

Sun Pharmaceutical Industries' Executive Chairman Dilip Shanghvi described the USD 11.75 billion acquisition of US-based Organon & Co as both a "happy" and "bit anxious" moment, acknowledging the significant debt required to fund the large transaction.

Stock Markets Today: Sensex, Nifty in Red; BSE tanked over 600 points

Stock Markets Today: Sensex, Nifty in Red; BSE tanked over 600 points

Rediff.com24 Sep 2026

Indian benchmark indices, Sensex and Nifty, experienced a significant drop in early trade, with the Sensex falling over 600 points, primarily due to crude oil prices surging past the USD 100 per barrel mark and weak global market trends. Track Sensex, Nifty on September 24.

FDA withdraws action on Pune Cipla unit, MCA eateries after HC rebuke

FDA withdraws action on Pune Cipla unit, MCA eateries after HC rebuke

Rediff.com29 Aug 2026

The Bombay High Court severely criticised the Maharashtra FDA for its "undue haste" and "high-handed" actions, forcing the regulator to withdraw orders against Cipla Pharma and five restaurants at the Mumbai Cricket Association premises. The court admonished the FDA for violating principles of natural justice and taking a "pedantic instead of pragmatic view," even threatening contempt action against officials.

NSE Rings The Gong At BSE

NSE Rings The Gong At BSE

Rediff.com24 Sep 2026

The National Stock Exchange marked its stock market debut at the Bombay Stock Exchange on September 24, 2026, with a traditional gong-ringing ceremony.

Symbiotec Pharmalab shares end over 11% higher after flat debut

Symbiotec Pharmalab shares end over 11% higher after flat debut

Rediff.com1 Sep 2026

Shares of Symbiotec Pharmalab Ltd, a pharma and biotech company, made a muted market debut, listing nearly 1 per cent lower on the BSE against its issue price of Rs 988, but later recovered to trade higher.

Stock Markets today: Sensex, Nifty Rebound on Sun Pharma Acquisition News

Stock Markets today: Sensex, Nifty Rebound on Sun Pharma Acquisition News

Rediff.com27 Apr 2026

Indian benchmark indices Sensex and Nifty rebounded in early trade after three days of decline, driven by a rally in Sun Pharma following its USD 11.75 billion acquisition of US-based Organon & Co, alongside a positive trend in global equity markets.

Cosmetics From Pakistan Breach Indian Market

Cosmetics From Pakistan Breach Indian Market

Rediff.com23 Sep 2026

CDSCO has warned consumers against using two unauthorised Pakistani whitening creams after finding excessive heavy metals and regulatory violations.

Stock Markets Today: Sensex, Nifty Flat in Early Trade; Oil Above $100

Stock Markets Today: Sensex, Nifty Flat in Early Trade; Oil Above $100

Rediff.com10 Sep 2026

Indian benchmark indices, Sensex and Nifty, traded flat in early deals due to elevated crude oil prices exceeding USD 100 per barrel and persistent geopolitical tensions, which subdued investor risk appetite.

Stock Markets Today: Sensex, Nifty dip on West Asia crisis, oil prices

Stock Markets Today: Sensex, Nifty dip on West Asia crisis, oil prices

Rediff.com8 Sep 2026

Indian benchmark indices, Sensex and Nifty, saw declines in early trade due to escalating crude oil prices and ongoing US-Iran hostilities, which subdued investor risk appetite.

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

Auto, Healthcare, Retail Drive 14% Rise in White-Collar Hiring

Auto, Healthcare, Retail Drive 14% Rise in White-Collar Hiring

Rediff.com8 Sep 2026

India's white-collar job market experienced a 14 per cent year-on-year growth in August, with the auto, healthcare, and retail sectors leading the surge, according to a report by Naukri.com.

5 Rakhi Ads That Melted Our Hearts

5 Rakhi Ads That Melted Our Hearts

Rediff.com27 Aug 2026

Five Raksha Bandhan ads that stayed with us long after the festival was over...

'If Earnings Growth Returns, Capital Can Flow Back To India'

'If Earnings Growth Returns, Capital Can Flow Back To India'

Rediff.com25 Aug 2026

'India is vulnerable to the West Asia crisis in three ways: Energy costs, the business Indian companies conduct in the region, and remittances from the Indian diaspora.'

Sensex, Nifty Fall for 5th Day on Crude Price Surge, West Asia Crisis

Sensex, Nifty Fall for 5th Day on Crude Price Surge, West Asia Crisis

Rediff.com17 Aug 2026

Indian benchmark indices, Sensex and Nifty, continued their downward trend for the fifth consecutive day, with the Sensex dropping 281 points and Nifty falling 78 points, primarily driven by surging crude oil prices and persistent geopolitical tensions in West Asia.

Indian Stocks Fall as West Asia Tensions Push Crude Oil Higher

Indian Stocks Fall as West Asia Tensions Push Crude Oil Higher

Rediff.com31 Aug 2026

Indian stock markets closed lower due to selling in IT and FMCG shares, triggered by renewed tensions in West Asia which led to a rally in crude oil prices and concerns over inflation and interest rates.

Sun Pharma's Organon deal: Strategic entry into new segments, but integration challenges loom

Sun Pharma's Organon deal: Strategic entry into new segments, but integration challenges loom

Rediff.com5 May 2026

Sun Pharmaceutical Industries' acquisition of US-based Organon & Co. for $11.75 billion, the largest overseas acquisition by an Indian pharma company, has been met with mixed reactions from brokerages, who see strategic entry into women's health and biosimilars but also flag potential integration challenges and debt concerns.

Stock Markets Today: Sensex, Nifty Sink on US-Iran Crisis

Stock Markets Today: Sensex, Nifty Sink on US-Iran Crisis

Rediff.com2 Sep 2026

Indian benchmark indices Sensex and Nifty experienced a significant slump in early trade, mirroring a bearish trend in global equities, as escalating conflict in West Asia drove up crude oil prices and intensified investor concerns.

US India Space Partnership: A New Era Of Co-Creation

US India Space Partnership: A New Era Of Co-Creation

Rediff.com7 Sep 2026

US Ambassador to India, Sergio Gor, highlighted the evolving US-India space partnership, moving from cooperation to "co-creation" at the Bengaluru Space Expo. He emphasised joint design, funding, and co-authoring the future of human discovery, citing the NISAR satellite and India's participation in the Artemis Accords as key examples of this growing synergy.

AI Effect: 'Nearly 3 Million Jobs Are At Risk In India'

AI Effect: 'Nearly 3 Million Jobs Are At Risk In India'

Rediff.com28 Aug 2026

In the next 36 months nearly 25 to 40 per cent of jobs will be under threat from AI and job losses are inevitable.

Maharashtra: Ayurvedic drug makers under FDA radar

Maharashtra: Ayurvedic drug makers under FDA radar

Rediff.com11 Aug 2026

The Maharashtra Food and Drug Administration (FDA) has cancelled the licences of 10 Ayurvedic drug manufacturing units and issued show-cause notices to 135 others following inspections that revealed serious violations including unhygienic conditions, lack of technical staff, and inadequate testing protocols.

Rising Crude Prices, US-Iran Tensions Drag Down Indian Equities

Rising Crude Prices, US-Iran Tensions Drag Down Indian Equities

Rediff.com19 Aug 2026

Indian benchmark equity indices, Sensex and Nifty, closed lower for multiple consecutive days, with the Nifty extending its losses to a seventh day, primarily due to elevated crude oil prices following the expiry of the US-Iran ceasefire without a diplomatic resolution.

Indian Markets Today: Sensex, Nifty Decline as Crude Hits $91

Indian Markets Today: Sensex, Nifty Decline as Crude Hits $91

Rediff.com18 Aug 2026

Indian benchmark indices Sensex and Nifty experienced declines in early trade, driven by a surge in Brent crude oil prices above USD 91 per barrel due to escalating tensions between Iran and the US, alongside an increase in US 10-year bond yields. Track Sensex, Nifty on August 18.

Stock Markets Today: Sensex, Nifty in Red on Rising Crude Prices

Stock Markets Today: Sensex, Nifty in Red on Rising Crude Prices

Rediff.com19 Aug 2026

Indian benchmark equity indices, Sensex and Nifty, experienced declines in early trade due to elevated crude oil prices and persistent geopolitical uncertainties, particularly following the expiry of the US-Iran ceasefire. Track Sensex, Nifty on August 19, 2026.

Chinese API price surge tests India's pharma buffers amid West Asia crisis

Chinese API price surge tests India's pharma buffers amid West Asia crisis

Rediff.com2 May 2026

India's pharmaceutical industry is experiencing increased bulk drug prices, particularly for APIs from China, following the escalation of the West Asia crisis in March. While current inventories provide a temporary buffer, concerns are mounting over the availability of key solvents and feedstocks, potentially leading to manufacturing disruptions and shortages in specific drug categories.

Indian Start-up Serendipity Space Achieves Drug Crystallisation In Near-Space

Indian Start-up Serendipity Space Achieves Drug Crystallisation In Near-Space

Rediff.com14 Aug 2026

Odisha-based Serendipity Space successfully demonstrated drug crystallisation processes on a satellite prototype in a near-space mission. This breakthrough aims to enable pharmaceutical manufacturing in low Earth orbit, leveraging microgravity to create superior drug crystal structures for enhanced solubility, stability, and effectiveness. The mission tested core technologies, including an autonomous pharmaceutical factory, and was inspired by advancements made on the International Space Station.

Stock Markets Today: Sensex, Nifty down on high crude prices and selling in bank stocks

Stock Markets Today: Sensex, Nifty down on high crude prices and selling in bank stocks

Rediff.com22 Jul 2026

Indian benchmark indices, Sensex and Nifty, experienced declines in early trade due to a surge in crude oil prices and significant selling pressure on bank stocks, impacting overall investor sentiment. Track Sensex, Nifty on July 22.

Ambanis Worth Rs 25.8 Trillion!

Ambanis Worth Rs 25.8 Trillion!

Rediff.com12 Aug 2026

India's 10 most valuable families had a combined valuation of Rs 70.5 trillion.